143PAurora Kinase A (AURKA) is an independent predictor of recurrence in breast ductal carcinoma in situ (DCIS)
Miligy, I M, Gaber, A, Toss, M S, Hamad, A, Nolan, C, Diez-Rodriguez, M, Ellis, I O, Green, A, Rakha, E
Published in Annals of oncology (01.03.2018)
Published in Annals of oncology (01.03.2018)
Get full text
Journal Article
Aurora Kinase A (AURKA) is an independent predictor of recurrence in breast ductal carcinoma in situ (DCIS)
Miligy, I.M., Gaber, A., Toss, M.S., Hamad, A., Nolan, C., Diez-Rodriguez, M., Ellis, I.O., Green, A., Rakha, E.
Published in Annals of oncology (01.03.2018)
Published in Annals of oncology (01.03.2018)
Get full text
Journal Article
Abstract P5-18-02: A quantitative centrosomal amplification score (CAS) predicts local recurrence in ductal carcinoma in situ
Mittal, K, Kaur, J, Wei, G, Toss, MS, Osan, RM, Janssen, EA, Søiland, H, Rakha, EA, Rida, PC, Aneja, R
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Published in Cancer research (Chicago, Ill.) (15.02.2019)
Get full text
Journal Article
PO-014 Targeting PARP1 in XRCC1 deficient sporadic invasive breast cancer or pre-invasive ductal carcinoma in situ for synthetic lethality and chemoprevention
Ali, R, Al-kawaz, A, Toss, MS, Green, A, Miligy, IA, Mesquita, K Almeida, Seedhouse, C, Mirza, S, Rakha, E, Madhusudan, S
Published in ESMO open (01.07.2018)
Published in ESMO open (01.07.2018)
Get full text
Journal Article